Potential efficacy of amnion epithelial cells to treat post-stroke inflammation

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

Abstract

Ischemic stroke is a crippling disease with few treatment options available. Thus there is an urgent need for novel therapies that can prevent or reverse the damaging effects of stroke. A promising experimental approach is stem cell therapy. Stem cells derived from human tissue, including embryonic, induced pluripotent, neural, and mesenchymal cells, are capable of rescuing injured brain tissue and improving functional recovery in experimental models of stroke. However, ethical issues, concerns regarding tumorigenicity, and diffi culty harvesting suffi cient cells may hamper their suitability as a widely available cell therapy for stroke patients. In contrast, placental- derived stem cells, particularly human amnion epithelial cells (hAECs), are abundant, non- immunogenic, non-tumorigenic and pose no ethical challenges. Surprisingly, hAECs have received little attention as a potential stroke therapy. This chapter will firstly describe the immune cell response and brain infl ammation after stroke, and then consider the potential for hAECs to improve stroke outcome given their unique properties. Protective actions of hAECs could involve modulation of the immune response, differentiation into neural tissue, re-innervation of lost connections, and secretion of important cytokines, growth factors, hormones and/or neurotransmitters to restore cellular function.
Original languageEnglish
Title of host publicationPerinatal Stem Cells
EditorsAnthony Atala, Sean V Murphy
Place of PublicationUSA
PublisherSpringer
Pages219 - 229
Number of pages11
Edition1st
ISBN (Print)9781493911172
DOIs
Publication statusPublished - 2014

Cite this

Broughton, Bradley R S ; Lim, Rebecca Seok Wai ; Evans, Megan A ; Drummond, Grant R ; Wallace, Euan M ; Sobey, Christopher G. / Potential efficacy of amnion epithelial cells to treat post-stroke inflammation. Perinatal Stem Cells. editor / Anthony Atala ; Sean V Murphy. 1st. ed. USA : Springer, 2014. pp. 219 - 229
@inbook{258b9c989e624360a106b41fb63d0775,
title = "Potential efficacy of amnion epithelial cells to treat post-stroke inflammation",
abstract = "Ischemic stroke is a crippling disease with few treatment options available. Thus there is an urgent need for novel therapies that can prevent or reverse the damaging effects of stroke. A promising experimental approach is stem cell therapy. Stem cells derived from human tissue, including embryonic, induced pluripotent, neural, and mesenchymal cells, are capable of rescuing injured brain tissue and improving functional recovery in experimental models of stroke. However, ethical issues, concerns regarding tumorigenicity, and diffi culty harvesting suffi cient cells may hamper their suitability as a widely available cell therapy for stroke patients. In contrast, placental- derived stem cells, particularly human amnion epithelial cells (hAECs), are abundant, non- immunogenic, non-tumorigenic and pose no ethical challenges. Surprisingly, hAECs have received little attention as a potential stroke therapy. This chapter will firstly describe the immune cell response and brain infl ammation after stroke, and then consider the potential for hAECs to improve stroke outcome given their unique properties. Protective actions of hAECs could involve modulation of the immune response, differentiation into neural tissue, re-innervation of lost connections, and secretion of important cytokines, growth factors, hormones and/or neurotransmitters to restore cellular function.",
author = "Broughton, {Bradley R S} and Lim, {Rebecca Seok Wai} and Evans, {Megan A} and Drummond, {Grant R} and Wallace, {Euan M} and Sobey, {Christopher G}",
year = "2014",
doi = "10.1007/978-1-4939-1118-9_20",
language = "English",
isbn = "9781493911172",
pages = "219 -- 229",
editor = "Anthony Atala and Murphy, {Sean V}",
booktitle = "Perinatal Stem Cells",
publisher = "Springer",
edition = "1st",

}

Potential efficacy of amnion epithelial cells to treat post-stroke inflammation. / Broughton, Bradley R S; Lim, Rebecca Seok Wai; Evans, Megan A; Drummond, Grant R; Wallace, Euan M; Sobey, Christopher G.

Perinatal Stem Cells. ed. / Anthony Atala; Sean V Murphy. 1st. ed. USA : Springer, 2014. p. 219 - 229.

Research output: Chapter in Book/Report/Conference proceedingChapter (Book)Researchpeer-review

TY - CHAP

T1 - Potential efficacy of amnion epithelial cells to treat post-stroke inflammation

AU - Broughton, Bradley R S

AU - Lim, Rebecca Seok Wai

AU - Evans, Megan A

AU - Drummond, Grant R

AU - Wallace, Euan M

AU - Sobey, Christopher G

PY - 2014

Y1 - 2014

N2 - Ischemic stroke is a crippling disease with few treatment options available. Thus there is an urgent need for novel therapies that can prevent or reverse the damaging effects of stroke. A promising experimental approach is stem cell therapy. Stem cells derived from human tissue, including embryonic, induced pluripotent, neural, and mesenchymal cells, are capable of rescuing injured brain tissue and improving functional recovery in experimental models of stroke. However, ethical issues, concerns regarding tumorigenicity, and diffi culty harvesting suffi cient cells may hamper their suitability as a widely available cell therapy for stroke patients. In contrast, placental- derived stem cells, particularly human amnion epithelial cells (hAECs), are abundant, non- immunogenic, non-tumorigenic and pose no ethical challenges. Surprisingly, hAECs have received little attention as a potential stroke therapy. This chapter will firstly describe the immune cell response and brain infl ammation after stroke, and then consider the potential for hAECs to improve stroke outcome given their unique properties. Protective actions of hAECs could involve modulation of the immune response, differentiation into neural tissue, re-innervation of lost connections, and secretion of important cytokines, growth factors, hormones and/or neurotransmitters to restore cellular function.

AB - Ischemic stroke is a crippling disease with few treatment options available. Thus there is an urgent need for novel therapies that can prevent or reverse the damaging effects of stroke. A promising experimental approach is stem cell therapy. Stem cells derived from human tissue, including embryonic, induced pluripotent, neural, and mesenchymal cells, are capable of rescuing injured brain tissue and improving functional recovery in experimental models of stroke. However, ethical issues, concerns regarding tumorigenicity, and diffi culty harvesting suffi cient cells may hamper their suitability as a widely available cell therapy for stroke patients. In contrast, placental- derived stem cells, particularly human amnion epithelial cells (hAECs), are abundant, non- immunogenic, non-tumorigenic and pose no ethical challenges. Surprisingly, hAECs have received little attention as a potential stroke therapy. This chapter will firstly describe the immune cell response and brain infl ammation after stroke, and then consider the potential for hAECs to improve stroke outcome given their unique properties. Protective actions of hAECs could involve modulation of the immune response, differentiation into neural tissue, re-innervation of lost connections, and secretion of important cytokines, growth factors, hormones and/or neurotransmitters to restore cellular function.

UR - http://download.springer.com/static/pdf/68/chp%253A10.1007%252F978-1-4939-1118-9_20.pdf?auth66=1425874426_3e148bd6d99b55a2162ee161eb4eb929&ext=.pdf

U2 - 10.1007/978-1-4939-1118-9_20

DO - 10.1007/978-1-4939-1118-9_20

M3 - Chapter (Book)

SN - 9781493911172

SP - 219

EP - 229

BT - Perinatal Stem Cells

A2 - Atala, Anthony

A2 - Murphy, Sean V

PB - Springer

CY - USA

ER -